EQT byder 6 mia for svenske Karo Pharma

Den svenske kapitalfond EQT har budt knap 6 mia. svenske kroner for det svenske helse- og medicinalselskab Karo Pharma, der for nylig købte 10 lægemidler af Leo Pharma. Aktien stiger med mere end 25 pct.
Photo: /ritzau/Thomas Borberg
Photo: /ritzau/Thomas Borberg

Svenske Karo Pharma, der i marts købte ti lægemidler fra Leo Pharma for en samlet pris på 2 mia. kr., er på nippet til at blive solgt til den svenske kapitalfond EQT.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading